[96a5a0]: / output / allTrials / identified / NCT06164691_identified.json

Download this file

276 lines (276 with data), 11.4 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
{
"info": {
"nct_id": "NCT06164691",
"official_title": "The Effect of Peri-surgery Blue and Amber Light Exposure in Subjects Undergoing Medical and Surgical Treatment of Cancer",
"inclusion_criteria": "1. greater than 18 and less than 80 years of age\n2. adenocarcinoma of the pancreas (unresectable) or adenocarcinoma of the rectum (stage II or III).\nHealthy volunteers allowed\nMust have minimum age of 19 Years\nMust have maximum age of 80 Years",
"exclusion_criteria": "1. Prior chemotherapy (inability to determine the integrity of the immune response)\n2. Autoimmune disorder, immunosuppression therapy, or immunocompromised state (inability to determine the integrity of the immune response)\n3. Blindness or other significant vision disorder or prior traumatic brain injury (the inability to determine the integrity of functional optic and suprachiasmatic pathways)\n4. Hematological disease - e.g., myelodysplastic syndrome, leukemia (inability to determine the integrity of the immune response)\n5. Bipolar disorder or schizophrenia (potential heightened symptoms)\n6. Refusal/ineligible to undergo neoadjuvant chemotherapy and/or radiation",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. greater than 18 and less than 80 years of age",
"criterions": [
{
"exact_snippets": "greater than 18 and less than 80 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 18,
"unit": "years"
},
{
"operator": "<",
"value": 80,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "2. adenocarcinoma of the pancreas (unresectable) or adenocarcinoma of the rectum (stage II or III).",
"criterions": [
{
"exact_snippets": "adenocarcinoma of the pancreas (unresectable)",
"criterion": "adenocarcinoma of the pancreas",
"requirements": [
{
"requirement_type": "resectability",
"expected_value": "unresectable"
}
]
},
{
"exact_snippets": "adenocarcinoma of the rectum (stage II or III)",
"criterion": "adenocarcinoma of the rectum",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"II",
"III"
]
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 19 Years",
"criterions": [
{
"exact_snippets": "minimum age of 19 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 19,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 80 Years",
"criterions": [
{
"exact_snippets": "maximum age of 80 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 80,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Prior chemotherapy (inability to determine the integrity of the immune response)",
"criterions": [
{
"exact_snippets": "Prior chemotherapy",
"criterion": "prior chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "2. Autoimmune disorder, immunosuppression therapy, or immunocompromised state (inability to determine the integrity of the immune response)",
"criterions": [
{
"exact_snippets": "Autoimmune disorder",
"criterion": "autoimmune disorder",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "immunosuppression therapy",
"criterion": "immunosuppression therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "immunocompromised state (inability to determine the integrity of the immune response)",
"criterion": "immunocompromised state",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "3. Blindness or other significant vision disorder or prior traumatic brain injury (the inability to determine the integrity of functional optic and suprachiasmatic pathways)",
"criterions": [
{
"exact_snippets": "Blindness or other significant vision disorder",
"criterion": "vision disorder",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "prior traumatic brain injury",
"criterion": "traumatic brain injury",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "4. Hematological disease - e.g., myelodysplastic syndrome, leukemia (inability to determine the integrity of the immune response)",
"criterions": [
{
"exact_snippets": "Hematological disease - e.g., myelodysplastic syndrome, leukemia",
"criterion": "hematological disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "inability to determine the integrity of the immune response",
"criterion": "integrity of the immune response",
"requirements": [
{
"requirement_type": "determinability",
"expected_value": false
}
]
}
]
},
{
"line": "5. Bipolar disorder or schizophrenia (potential heightened symptoms)",
"criterions": [
{
"exact_snippets": "Bipolar disorder",
"criterion": "bipolar disorder",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "schizophrenia",
"criterion": "schizophrenia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "6. Refusal/ineligible to undergo neoadjuvant chemotherapy and/or radiation",
"criterions": [
{
"exact_snippets": "Refusal/ineligible to undergo neoadjuvant chemotherapy",
"criterion": "neoadjuvant chemotherapy",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
},
{
"exact_snippets": "Refusal/ineligible to undergo ... radiation",
"criterion": "radiation",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}